Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes

Obesity Surgery

Volumn 26, Issue 8, 2016, Pages 1924-1931

  Thomas, Felicity ^a   Smith, Greg C ^b   Lu, Jun ^c   Babor, Richard ^d   Booth, Michael ^e   Beban, Grant ^f   Chase, J Geoffrey ^a   Murphy, Rinki ^g  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d MIDDLEMORE HOSPITAL   (New Zealand)

^e Waitemata and Auckland District Health Boards   (New Zealand)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Insulin secretion; Non esterified fatty acid; Obesity; Roux en Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes; Very low calorie diet

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN; LINOLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GASTRIC BYPASS SURGERY; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LOW CALORY DIET; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); STATISTICAL ANALYSIS; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FATTY ACIDS; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 84952918084     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-2038-3     Document Type: Article

References (31)

1. Kashyap SR et al. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med. 2010;77(7):468–76.
2. Buchwald H et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–U81.
3. Pories WJ et al. Who would have thought it—an operation proves to be the most effective therapy for adult-onset diabetes-mellitus. Ann Surg. 1995;222(3):339–52.
4. Isbell JM et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010;33(7):1438–42.
5. Kashyap SR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes. 2010;34(3):462–71.
6. Bayham BE et al. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther. 2012;14(1):30–4.
7. Ramon JM et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg. 2012;16(6):1116–22.
8. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1985;61(5):917–25.
9. Lim EL et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.
10. Salinari S et al. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia. 2008;51(7):1276–84.
11. Reaven GM et al. Measurement of plasma-glucose, free fatty-acid, lactate, and insulin for 24-H in patients with NIDDM. Diabetes. 1988;37(8):1020–4.
12. Yue KT et al. Effect of glucose on plasma concentrations of individual non-esterified fatty acids of non-diabetic and insulin-independent diabetic men. Postgrad Med J. 1981;57(672):622–6.
13. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003;14(3):281–7.
14. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM—genetic and clinical implications. Diabetes. 1995;44(8):863–70.
15. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42(2):128–38.
16. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin-secretion and B-cell oxidation through a process likely coupled to fatty-acid oxidation. Endocrinology. 1990;127(4):1580–9.
17. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3–10.
18. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Investig. 2000;106(2):171–6.
19. Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.
20. Bierman EL, Schwartz IL, Dole VP. Action of insulin on release of fatty acids from tissue stores. Am J Physiol. 1957;191(2):359–62.
21. Hirsch J, Goldrick RB. Serial studies on the metabolism of human adipose tissue. I. Lipogenesis and free fatty acid uptake and release in small aspirated samples of subcutaneous fat. J Clin Invest. 1964;43:1776–92.
22. Gray DS et al. Changes in individual plasma free fatty acids in obese females during fasting and refeeding. Int J Obes. 1991;15(2):163–8.
23. Van Cauter E et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368–77.
24. Lee WJ et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.
25. Schauer PR et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
26. Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358–63.
27. Ballantyne GH et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16(9):1189–97.
28. Camastra S et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care. 2007;30(4):1002–4.
29. Mari A et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49(9):2136–43.
30. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32(3):514–20.
31. Yip S et al. Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction. Obes Surg. 2014;24(1):62–70.